Recent News

• 03.11.2026 - Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
• 03.11.2026 - Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
• 03.04.2026 - Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform
• 02.25.2026 - Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
• 02.17.2026 - Codexis to Participate in TD Cowen 46th Annual Health Care Conference
• 02.10.2026 - Codexis Achieves ISO 9001:2015 Certification
• 01.07.2026 - Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

Recent Filings

• 02.25.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.23.2026 - 144 Report of proposed sale of securities
• 02.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2026 - 144 Report of proposed sale of securities
• 02.06.2026 - 144 Report of proposed sale of securities
• 01.23.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors